nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN3A—spinal nerve—germ cell cancer	0.1	0.193	CbGeAlD
Mepivacaine—Cranial nerve paralysis—Methotrexate—germ cell cancer	0.0269	0.0792	CcSEcCtD
Mepivacaine—SCN10A—ganglion—germ cell cancer	0.021	0.0403	CbGeAlD
Mepivacaine—Meningism—Methotrexate—germ cell cancer	0.0179	0.0526	CcSEcCtD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—ZFP42—germ cell cancer	0.0144	0.104	CbGpPWpGaD
Mepivacaine—SCN8A—brainstem—germ cell cancer	0.0136	0.0262	CbGeAlD
Mepivacaine—SCN9A—trigeminal ganglion—germ cell cancer	0.0135	0.026	CbGeAlD
Mepivacaine—SCN8A—telencephalon—germ cell cancer	0.0121	0.0232	CbGeAlD
Mepivacaine—Acidosis—Ifosfamide—germ cell cancer	0.0119	0.0348	CcSEcCtD
Mepivacaine—SCN10A—trigeminal ganglion—germ cell cancer	0.0103	0.0198	CbGeAlD
Mepivacaine—SCN1A—brainstem—germ cell cancer	0.0103	0.0198	CbGeAlD
Mepivacaine—SCN2A—brainstem—germ cell cancer	0.00945	0.0181	CbGeAlD
Mepivacaine—SCN1A—telencephalon—germ cell cancer	0.00913	0.0175	CbGeAlD
Mepivacaine—Ventricular arrhythmia—Ifosfamide—germ cell cancer	0.00887	0.0261	CcSEcCtD
Mepivacaine—SCN9A—pituitary gland—germ cell cancer	0.00864	0.0166	CbGeAlD
Mepivacaine—SCN8A—spinal cord—germ cell cancer	0.00846	0.0163	CbGeAlD
Mepivacaine—SCN2A—telencephalon—germ cell cancer	0.00838	0.0161	CbGeAlD
Mepivacaine—SCN10A—telencephalon—germ cell cancer	0.00808	0.0155	CbGeAlD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—SOX17—germ cell cancer	0.00792	0.0569	CbGpPWpGaD
Mepivacaine—SCN9A—adrenal gland—germ cell cancer	0.00772	0.0148	CbGeAlD
Mepivacaine—SCN4A—pituitary gland—germ cell cancer	0.00771	0.0148	CbGeAlD
Mepivacaine—SCN9A—midbrain—germ cell cancer	0.00762	0.0146	CbGeAlD
Mepivacaine—SCN8A—endocrine gland—germ cell cancer	0.00762	0.0146	CbGeAlD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—NANOG—germ cell cancer	0.00759	0.0545	CbGpPWpGaD
Mepivacaine—SCN8A—head—germ cell cancer	0.00752	0.0145	CbGeAlD
Mepivacaine—SCN9A—spinal cord—germ cell cancer	0.00744	0.0143	CbGeAlD
Mepivacaine—SCN3A—telencephalon—germ cell cancer	0.00737	0.0142	CbGeAlD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—POU5F1—germ cell cancer	0.00731	0.0525	CbGpPWpGaD
Mepivacaine—SCN8A—testis—germ cell cancer	0.00727	0.014	CbGeAlD
Mepivacaine—SCN1A—medulla oblongata—germ cell cancer	0.00718	0.0138	CbGeAlD
Mepivacaine—SCN3A—decidua—germ cell cancer	0.00698	0.0134	CbGeAlD
Mepivacaine—SCN4A—adrenal gland—germ cell cancer	0.00689	0.0132	CbGeAlD
Mepivacaine—SCN2A—pituitary gland—germ cell cancer	0.00682	0.0131	CbGeAlD
Mepivacaine—SCN8A—cerebellum—germ cell cancer	0.00671	0.0129	CbGeAlD
Mepivacaine—SCN2A—medulla oblongata—germ cell cancer	0.00659	0.0127	CbGeAlD
Mepivacaine—SCN10A—pituitary gland—germ cell cancer	0.00658	0.0126	CbGeAlD
Mepivacaine—SCN1A—midbrain—germ cell cancer	0.00656	0.0126	CbGeAlD
Mepivacaine—SCN1A—spinal cord—germ cell cancer	0.0064	0.0123	CbGeAlD
Mepivacaine—SCN9A—testis—germ cell cancer	0.00639	0.0123	CbGeAlD
Mepivacaine—Urinary incontinence—Ifosfamide—germ cell cancer	0.00634	0.0186	CcSEcCtD
Mepivacaine—Apnoea—Etoposide—germ cell cancer	0.00612	0.018	CcSEcCtD
Mepivacaine—SCN2A—midbrain—germ cell cancer	0.00602	0.0116	CbGeAlD
Mepivacaine—SCN3A—pituitary gland—germ cell cancer	0.006	0.0115	CbGeAlD
Mepivacaine—SCN4A—head—germ cell cancer	0.0059	0.0113	CbGeAlD
Mepivacaine—SCN2A—spinal cord—germ cell cancer	0.00587	0.0113	CbGeAlD
Mepivacaine—SCN3A—medulla oblongata—germ cell cancer	0.00579	0.0111	CbGeAlD
Mepivacaine—SCN4A—testis—germ cell cancer	0.0057	0.0109	CbGeAlD
Mepivacaine—SCN1A—head—germ cell cancer	0.00569	0.0109	CbGeAlD
Mepivacaine—SCN10A—spinal cord—germ cell cancer	0.00566	0.0109	CbGeAlD
Mepivacaine—SCN8A—brain—germ cell cancer	0.00545	0.0105	CbGeAlD
Mepivacaine—Swelling—Ifosfamide—germ cell cancer	0.0054	0.0159	CcSEcCtD
Mepivacaine—SCN3A—adrenal gland—germ cell cancer	0.00536	0.0103	CbGeAlD
Mepivacaine—SCN3A—midbrain—germ cell cancer	0.00529	0.0102	CbGeAlD
Mepivacaine—SCN2A—endocrine gland—germ cell cancer	0.00529	0.0102	CbGeAlD
Mepivacaine—SCN2A—head—germ cell cancer	0.00522	0.01	CbGeAlD
Mepivacaine—SCN3A—bone marrow—germ cell cancer	0.00518	0.00996	CbGeAlD
Mepivacaine—SCN3A—spinal cord—germ cell cancer	0.00516	0.00992	CbGeAlD
Mepivacaine—SCN10A—endocrine gland—germ cell cancer	0.0051	0.0098	CbGeAlD
Mepivacaine—SCN1A—cerebellum—germ cell cancer	0.00507	0.00975	CbGeAlD
Mepivacaine—SCN10A—head—germ cell cancer	0.00503	0.00967	CbGeAlD
Mepivacaine—SCN9A—brain—germ cell cancer	0.00479	0.00921	CbGeAlD
Mepivacaine—SCN2A—cerebellum—germ cell cancer	0.00466	0.00895	CbGeAlD
Mepivacaine—SCN9A—lymph node—germ cell cancer	0.00463	0.00889	CbGeAlD
Mepivacaine—SCN3A—head—germ cell cancer	0.00459	0.00881	CbGeAlD
Mepivacaine—SCN5A—head—germ cell cancer	0.00457	0.00879	CbGeAlD
Mepivacaine—Cardiac arrest—Ifosfamide—germ cell cancer	0.00453	0.0133	CcSEcCtD
Mepivacaine—Urinary retention—Ifosfamide—germ cell cancer	0.00453	0.0133	CcSEcCtD
Mepivacaine—Paralysis—Methotrexate—germ cell cancer	0.00447	0.0131	CcSEcCtD
Mepivacaine—SCN3A—testis—germ cell cancer	0.00443	0.00851	CbGeAlD
Mepivacaine—SCN4A—brain—germ cell cancer	0.00427	0.00821	CbGeAlD
Mepivacaine—Swelling—Etoposide—germ cell cancer	0.00427	0.0125	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00424	0.0125	CcSEcCtD
Mepivacaine—SCN1A—brain—germ cell cancer	0.00412	0.00792	CbGeAlD
Mepivacaine—SCN3A—cerebellum—germ cell cancer	0.00409	0.00786	CbGeAlD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—SOX2—germ cell cancer	0.00405	0.0291	CbGpPWpGaD
Mepivacaine—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00389	0.0114	CcSEcCtD
Mepivacaine—SCN2A—brain—germ cell cancer	0.00378	0.00727	CbGeAlD
Mepivacaine—Apnoea—Methotrexate—germ cell cancer	0.00366	0.0108	CcSEcCtD
Mepivacaine—SCN10A—brain—germ cell cancer	0.00365	0.00701	CbGeAlD
Mepivacaine—Cardiac arrest—Etoposide—germ cell cancer	0.00358	0.0105	CcSEcCtD
Mepivacaine—SCN10A—lymph node—germ cell cancer	0.00352	0.00677	CbGeAlD
Mepivacaine—Chills—Bleomycin—germ cell cancer	0.00346	0.0102	CcSEcCtD
Mepivacaine—Sweating increased—Cisplatin—germ cell cancer	0.00346	0.0102	CcSEcCtD
Mepivacaine—Convulsion—Vinblastine—germ cell cancer	0.00344	0.0101	CcSEcCtD
Mepivacaine—Hypertension—Vinblastine—germ cell cancer	0.00343	0.0101	CcSEcCtD
Mepivacaine—Erythema—Bleomycin—germ cell cancer	0.00336	0.00987	CcSEcCtD
Mepivacaine—Bradycardia—Ifosfamide—germ cell cancer	0.00336	0.00986	CcSEcCtD
Mepivacaine—SCN3A—brain—germ cell cancer	0.00332	0.00639	CbGeAlD
Mepivacaine—SCN5A—brain—germ cell cancer	0.00331	0.00637	CbGeAlD
Mepivacaine—Chills—Dactinomycin—germ cell cancer	0.00323	0.00949	CcSEcCtD
Mepivacaine—SCN3A—lymph node—germ cell cancer	0.00321	0.00617	CbGeAlD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.0032	0.023	CbGpPWpGaD
Mepivacaine—Sweating increased—Etoposide—germ cell cancer	0.00317	0.00931	CcSEcCtD
Mepivacaine—Erythema—Dactinomycin—germ cell cancer	0.00313	0.0092	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—TDGF1—germ cell cancer	0.0031	0.0222	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00308	0.0221	CbGpPWpGaD
Mepivacaine—Tinnitus—Ifosfamide—germ cell cancer	0.00307	0.00903	CcSEcCtD
Mepivacaine—Chills—Ifosfamide—germ cell cancer	0.00296	0.00869	CcSEcCtD
Mepivacaine—Paraesthesia—Vinblastine—germ cell cancer	0.00291	0.00856	CcSEcCtD
Mepivacaine—Bradycardia—Cisplatin—germ cell cancer	0.00289	0.0085	CcSEcCtD
Mepivacaine—Erythema—Ifosfamide—germ cell cancer	0.00287	0.00843	CcSEcCtD
Mepivacaine—Oedema—Bleomycin—germ cell cancer	0.00274	0.00805	CcSEcCtD
Mepivacaine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00274	0.00805	CcSEcCtD
Mepivacaine—Vision blurred—Ifosfamide—germ cell cancer	0.0027	0.00795	CcSEcCtD
Mepivacaine—Tinnitus—Cisplatin—germ cell cancer	0.00265	0.00779	CcSEcCtD
Mepivacaine—Agitation—Ifosfamide—germ cell cancer	0.00264	0.00775	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—SALL4—germ cell cancer	0.00263	0.0189	CbGpPWpGaD
Mepivacaine—Angioedema—Ifosfamide—germ cell cancer	0.00262	0.00771	CcSEcCtD
Mepivacaine—Hypotension—Bleomycin—germ cell cancer	0.00256	0.00752	CcSEcCtD
Mepivacaine—Oedema—Dactinomycin—germ cell cancer	0.00256	0.00751	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—NANOG—germ cell cancer	0.00253	0.0181	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TDGF1—germ cell cancer	0.00251	0.018	CbGpPWpGaD
Mepivacaine—Convulsion—Ifosfamide—germ cell cancer	0.00249	0.00731	CcSEcCtD
Mepivacaine—Hypertension—Ifosfamide—germ cell cancer	0.00248	0.00728	CcSEcCtD
Mepivacaine—Erythema—Cisplatin—germ cell cancer	0.00247	0.00727	CcSEcCtD
Mepivacaine—Paraesthesia—Bleomycin—germ cell cancer	0.00246	0.00723	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—POU5F1—germ cell cancer	0.00243	0.0175	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TDGF1—germ cell cancer	0.0024	0.0172	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Vinblastine—germ cell cancer	0.00239	0.00702	CcSEcCtD
Mepivacaine—Oedema—Ifosfamide—germ cell cancer	0.00234	0.00688	CcSEcCtD
Mepivacaine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00234	0.00688	CcSEcCtD
Mepivacaine—Chills—Etoposide—germ cell cancer	0.00234	0.00686	CcSEcCtD
Mepivacaine—Vision blurred—Cisplatin—germ cell cancer	0.00233	0.00685	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00233	0.00684	CcSEcCtD
Mepivacaine—Asthenia—Vinblastine—germ cell cancer	0.00233	0.00684	CcSEcCtD
Mepivacaine—Tremor—Cisplatin—germ cell cancer	0.00232	0.00681	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—TDGF1—germ cell cancer	0.0023	0.0165	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TDGF1—germ cell cancer	0.0023	0.0165	CbGpPWpGaD
Mepivacaine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00226	0.00665	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—TDGF1—germ cell cancer	0.00222	0.0159	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TDGF1—germ cell cancer	0.00222	0.0159	CbGpPWpGaD
Mepivacaine—Back pain—Etoposide—germ cell cancer	0.00219	0.00644	CcSEcCtD
Mepivacaine—Hypotension—Ifosfamide—germ cell cancer	0.00219	0.00643	CcSEcCtD
Mepivacaine—Urticaria—Bleomycin—germ cell cancer	0.00218	0.0064	CcSEcCtD
Mepivacaine—Body temperature increased—Bleomycin—germ cell cancer	0.00217	0.00637	CcSEcCtD
Mepivacaine—Dizziness—Vinblastine—germ cell cancer	0.00215	0.00631	CcSEcCtD
Mepivacaine—Convulsion—Cisplatin—germ cell cancer	0.00214	0.0063	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—SALL4—germ cell cancer	0.00213	0.0153	CbGpPWpGaD
Mepivacaine—Paraesthesia—Ifosfamide—germ cell cancer	0.0021	0.00618	CcSEcCtD
Mepivacaine—Anxiety—Cisplatin—germ cell cancer	0.0021	0.00617	CcSEcCtD
Mepivacaine—Somnolence—Ifosfamide—germ cell cancer	0.00208	0.00612	CcSEcCtD
Mepivacaine—Vomiting—Vinblastine—germ cell cancer	0.00206	0.00606	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—NANOG—germ cell cancer	0.00204	0.0147	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SALL4—germ cell cancer	0.00204	0.0146	CbGpPWpGaD
Mepivacaine—Headache—Vinblastine—germ cell cancer	0.00203	0.00597	CcSEcCtD
Mepivacaine—Body temperature increased—Dactinomycin—germ cell cancer	0.00202	0.00594	CcSEcCtD
Mepivacaine—Oedema—Cisplatin—germ cell cancer	0.00202	0.00593	CcSEcCtD
Mepivacaine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00202	0.00593	CcSEcCtD
Mepivacaine—Hypersensitivity—Bleomycin—germ cell cancer	0.00202	0.00593	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—germ cell cancer	0.00199	0.00585	CcSEcCtD
Mepivacaine—Tachycardia—Cisplatin—germ cell cancer	0.00197	0.00579	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—POU5F1—germ cell cancer	0.00197	0.0141	CbGpPWpGaD
Mepivacaine—Asthenia—Bleomycin—germ cell cancer	0.00197	0.00578	CcSEcCtD
Mepivacaine—Convulsion—Etoposide—germ cell cancer	0.00196	0.00577	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—SALL4—germ cell cancer	0.00196	0.0141	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SALL4—germ cell cancer	0.00196	0.0141	CbGpPWpGaD
Mepivacaine—Hypertension—Etoposide—germ cell cancer	0.00196	0.00575	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—NANOG—germ cell cancer	0.00195	0.014	CbGpPWpGaD
Mepivacaine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00195	0.00574	CcSEcCtD
Mepivacaine—Pruritus—Bleomycin—germ cell cancer	0.00194	0.0057	CcSEcCtD
Mepivacaine—Nausea—Vinblastine—germ cell cancer	0.00193	0.00566	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—KLF4—germ cell cancer	0.00191	0.0137	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SALL4—germ cell cancer	0.00189	0.0136	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SALL4—germ cell cancer	0.00189	0.0136	CbGpPWpGaD
Mepivacaine—Hypotension—Cisplatin—germ cell cancer	0.00189	0.00554	CcSEcCtD
Mepivacaine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00188	0.00553	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—POU5F1—germ cell cancer	0.00188	0.0135	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NANOG—germ cell cancer	0.00188	0.0135	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NANOG—germ cell cancer	0.00188	0.0135	CbGpPWpGaD
Mepivacaine—Urticaria—Ifosfamide—germ cell cancer	0.00186	0.00547	CcSEcCtD
Mepivacaine—Body temperature increased—Ifosfamide—germ cell cancer	0.00185	0.00544	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—germ cell cancer	0.00185	0.00544	CcSEcCtD
Mepivacaine—Asthenia—Dactinomycin—germ cell cancer	0.00183	0.00539	CcSEcCtD
Mepivacaine—Paraesthesia—Cisplatin—germ cell cancer	0.00181	0.00533	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—NANOG—germ cell cancer	0.00181	0.013	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NANOG—germ cell cancer	0.00181	0.013	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—POU5F1—germ cell cancer	0.00181	0.013	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—POU5F1—germ cell cancer	0.00181	0.013	CbGpPWpGaD
Mepivacaine—Tachycardia—Etoposide—germ cell cancer	0.00181	0.00531	CcSEcCtD
Mepivacaine—Hyperhidrosis—Etoposide—germ cell cancer	0.00179	0.00525	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—POU5F1—germ cell cancer	0.00174	0.0125	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—POU5F1—germ cell cancer	0.00174	0.0125	CbGpPWpGaD
Mepivacaine—Vomiting—Bleomycin—germ cell cancer	0.00174	0.00512	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—germ cell cancer	0.00174	0.0051	CcSEcCtD
Mepivacaine—Hypotension—Etoposide—germ cell cancer	0.00173	0.00508	CcSEcCtD
Mepivacaine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00173	0.00507	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00171	0.0123	CbGpPWpGaD
Mepivacaine—Asthenia—Ifosfamide—germ cell cancer	0.00168	0.00494	CcSEcCtD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—KIT—germ cell cancer	0.00167	0.012	CbGpPWpGaD
Mepivacaine—Sweating—Methotrexate—germ cell cancer	0.00167	0.00489	CcSEcCtD
Mepivacaine—Paraesthesia—Etoposide—germ cell cancer	0.00166	0.00488	CcSEcCtD
Mepivacaine—Pruritus—Ifosfamide—germ cell cancer	0.00166	0.00487	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—germ cell cancer	0.00164	0.00483	CcSEcCtD
Mepivacaine—Nausea—Bleomycin—germ cell cancer	0.00163	0.00478	CcSEcCtD
Mepivacaine—Vomiting—Dactinomycin—germ cell cancer	0.00162	0.00478	CcSEcCtD
Mepivacaine—Body temperature increased—Cisplatin—germ cell cancer	0.0016	0.00469	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—TDGF1—germ cell cancer	0.00156	0.0112	CbGpPWpGaD
Mepivacaine—Dizziness—Ifosfamide—germ cell cancer	0.00155	0.00455	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—KLF4—germ cell cancer	0.00155	0.0111	CbGpPWpGaD
Mepivacaine—Nausea—Dactinomycin—germ cell cancer	0.00152	0.00446	CcSEcCtD
Mepivacaine—Vomiting—Ifosfamide—germ cell cancer	0.00149	0.00438	CcSEcCtD
Mepivacaine—Hypersensitivity—Cisplatin—germ cell cancer	0.00149	0.00437	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—KLF4—germ cell cancer	0.00148	0.0106	CbGpPWpGaD
Mepivacaine—Urticaria—Etoposide—germ cell cancer	0.00147	0.00432	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—germ cell cancer	0.00146	0.0043	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—germ cell cancer	0.00145	0.00427	CcSEcCtD
Mepivacaine—Asthenia—Cisplatin—germ cell cancer	0.00145	0.00426	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—KLF4—germ cell cancer	0.00142	0.0102	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KLF4—germ cell cancer	0.00142	0.0102	CbGpPWpGaD
Mepivacaine—Chills—Methotrexate—germ cell cancer	0.0014	0.00411	CcSEcCtD
Mepivacaine—Nausea—Ifosfamide—germ cell cancer	0.00139	0.00409	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—KLF4—germ cell cancer	0.00137	0.00985	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KLF4—germ cell cancer	0.00137	0.00985	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Etoposide—germ cell cancer	0.00136	0.004	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—germ cell cancer	0.00136	0.00399	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—SOX2—germ cell cancer	0.00135	0.00968	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SALL4—germ cell cancer	0.00133	0.00953	CbGpPWpGaD
Mepivacaine—Asthenia—Etoposide—germ cell cancer	0.00133	0.0039	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—germ cell cancer	0.00131	0.00386	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—germ cell cancer	0.00131	0.00385	CcSEcCtD
Mepivacaine—Vomiting—Cisplatin—germ cell cancer	0.00128	0.00377	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—germ cell cancer	0.00128	0.00376	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—NANOG—germ cell cancer	0.00127	0.00914	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—POU5F1—germ cell cancer	0.00122	0.0088	CbGpPWpGaD
Mepivacaine—Dizziness—Etoposide—germ cell cancer	0.00122	0.00359	CcSEcCtD
Mepivacaine—Nausea—Cisplatin—germ cell cancer	0.0012	0.00352	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—germ cell cancer	0.00118	0.00346	CcSEcCtD
Mepivacaine—Vomiting—Etoposide—germ cell cancer	0.00118	0.00346	CcSEcCtD
Mepivacaine—Headache—Etoposide—germ cell cancer	0.00116	0.00341	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—germ cell cancer	0.00111	0.00326	CcSEcCtD
Mepivacaine—Nausea—Etoposide—germ cell cancer	0.0011	0.00323	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—SOX2—germ cell cancer	0.00109	0.00783	CbGpPWpGaD
Mepivacaine—Hyperhidrosis—Methotrexate—germ cell cancer	0.00107	0.00315	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—SOX2—germ cell cancer	0.00104	0.00749	CbGpPWpGaD
Mepivacaine—Hypotension—Methotrexate—germ cell cancer	0.00104	0.00304	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.00101	0.00723	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SOX2—germ cell cancer	0.001	0.0072	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SOX2—germ cell cancer	0.001	0.0072	CbGpPWpGaD
Mepivacaine—Paraesthesia—Methotrexate—germ cell cancer	0.000995	0.00292	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—germ cell cancer	0.000985	0.00289	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—SOX2—germ cell cancer	0.000967	0.00694	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SOX2—germ cell cancer	0.000967	0.00694	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KLF4—germ cell cancer	0.000964	0.00693	CbGpPWpGaD
Mepivacaine—Urticaria—Methotrexate—germ cell cancer	0.00088	0.00259	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—germ cell cancer	0.000876	0.00257	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—germ cell cancer	0.000816	0.0024	CcSEcCtD
Mepivacaine—Asthenia—Methotrexate—germ cell cancer	0.000795	0.00234	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—germ cell cancer	0.000784	0.0023	CcSEcCtD
Mepivacaine—Dizziness—Methotrexate—germ cell cancer	0.000733	0.00215	CcSEcCtD
Mepivacaine—Vomiting—Methotrexate—germ cell cancer	0.000704	0.00207	CcSEcCtD
Mepivacaine—Headache—Methotrexate—germ cell cancer	0.000694	0.00204	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—SOX2—germ cell cancer	0.000679	0.00488	CbGpPWpGaD
Mepivacaine—Nausea—Methotrexate—germ cell cancer	0.000658	0.00193	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—HRAS—germ cell cancer	0.000336	0.00241	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—germ cell cancer	0.000272	0.00195	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—germ cell cancer	0.00026	0.00187	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—germ cell cancer	0.00025	0.00179	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—germ cell cancer	0.00025	0.00179	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—germ cell cancer	0.000241	0.00173	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—germ cell cancer	0.000241	0.00173	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—germ cell cancer	0.00024	0.00172	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—germ cell cancer	0.000194	0.00139	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—germ cell cancer	0.000186	0.00133	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—germ cell cancer	0.000178	0.00128	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—germ cell cancer	0.000178	0.00128	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—germ cell cancer	0.000172	0.00123	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—germ cell cancer	0.000172	0.00123	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—germ cell cancer	0.000169	0.00122	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—germ cell cancer	0.000121	0.000868	CbGpPWpGaD
